Study to Evaluate the Safety and Efficacy of Minocycline Ointment in Subjects With Inflamed Meibomian Gland Dysfunction

NCT03888378 · clinicaltrials.gov ↗

PHASE2

Phase

COMPLETED

Status

270

Enrollment

INDUSTRY

Sponsor class

Conditions

Meibomian Gland Dysfunction
MGD-Meibomian Gland Dysfunction

Interventions

DRUG: 0.3% Topical Minocycline Ointment
DRUG: 1% Topical Minocycline Ointment
OTHER: Topical Vehicle Ointment

Sponsor

Hovione Scientia Limited